Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06636045

Blood Flow Restriction Following ACLR w/Quad Autograft

Effect of Blood Flow Restriction (BFR) on Rehabilitation Protocols Following Anterior Cruciate Ligament Reconstruction (ACLR) With Quadricep Autograft

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
University of Kansas Medical Center · Academic / Other
Sex
All
Age
14 Years – 40 Years
Healthy volunteers
Not accepted

Summary

This project is intended to acquire objective measurements of implementing BFR rehabilitation in ACL reconstructions to show any changes upon completion of the BFR protocol. The results in this study will hopefully represent valuable data in the support of using autografts for ACL reconstructions in high level athletes wanting a full recovery and return to high level of sport. It has been speculated that use of autografts in ACL reconstructions leads to more quad weakness and muscle atrophy due to tendon harvesting. (Slone et al., 2015) More recently, BFR has shown promise in expediting the recovery and rehabilitation process post-surgically. By implementing BFR following ACL reconstructions with autografts, we hope to mitigate the major deterrent for autograft use and giving patients a more cost-effective approach to surgery. (Hughes et al., 2019)

Detailed description

Specific Aim 1 will identify the overall preservation of muscle and changes in body composition after injury and throughout surgical rehabilitation in athletes undergoing ACL reconstruction. It is hypothesized that implementing BFR rehabilitation protocols following ACL reconstruction with autografts will expedite recovery and return to sport and rescue of muscle tissue at the donor site. Specific Aim 2 will monitor muscle strength and activation following ACL reconstruction with performance of standardized assessments at intervals. It is hypothesized that BFR implementation will show greater return to strength and enhanced muscle activation during testing.

Conditions

Interventions

TypeNameDescription
OTHERNot applicable- observational studyNo intervention. Observational study.

Timeline

Start date
2024-09-05
Primary completion
2026-10-01
Completion
2027-06-01
First posted
2024-10-10
Last updated
2025-04-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06636045. Inclusion in this directory is not an endorsement.